Myriam Rai
Friedreich's Ataxia Research Alliance(US)
Publications by Year
Research Areas
Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology, Osteoarthritis Treatment and Mechanisms, Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments
Most-Cited Works
- → HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model(2008)211 cited
- → Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study(2016)151 cited
- → Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia(2012)148 cited
- → Epigenetic therapy for Friedreich ataxia(2014)146 cited
- → Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model(2010)143 cited
- → Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich’s ataxia(2009)121 cited
- → Central role and mechanisms of β‐cell dysfunction and death in friedreich ataxia–associated diabetes(2012)93 cited
- → Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study(2021)90 cited
- Anti-diabetic effects of Tinospora cardifolia. I. Effect on fasting blood sugar level, glucose tolerance and adrenaline induced hyperglycaemia.(1967)
- → Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia(2019)73 cited